Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Golimumab in Chinese Patients with Active Rheumatoid Arthritis
NCT01248780Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Sep 2010
- Primary completion
- Oct 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of golimumab in rheumatoid arthritis (RA), sponsored by Janssen Pharmaceutical. Started Sep 2010; status: completed.
02
Drugs
golimumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01248780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01248780.